The long perspective in emergence of neoadjuvant chemotherapy for bladder cancer in Ontario, Canada—space for improvement with regular and organized multidisciplinary team meetings

Booth et al. investigate the increasing use of chemotherapy for bladder cancer in the Canadian province of Ontario, in the years 1994 to 2013, in the recently published paper: ”Perioperative chemotherapy for bladder cancer in the general population: Are practice patterns finally changing?” The study was a population-based retrospective cohort study and investigated both referrals to medical oncologists (MO) as well as utilization of perioperative chemotherapy in terms of neoadjuvant chemotherapy (NACT) and also adjuvant chemotherapy (ACT) (1).